# Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration

> **NCT00987376** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 8 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** Diagnostic Imaging: C11 choline PET; C11 acetate PET; and MRI Spectroscopy

## Key facts

- **NCT ID:** NCT00987376
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2016-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00987376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00987376, "Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00987376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*